-
New Masitinib Study Will Test Oral Treatments for ALS
AB Science’s new masitinib study, validated by the European Medicines Agency, will test the oral treatment in people with mildly severe ALS. Learn more about this study here.
What do you think of this research?
Sorry, there were no replies found.
Log in to reply.